| Literature DB >> 33115770 |
Keisuke Hosoki1, Yu Mikami1, Hirokazu Urushiyama1, Kunihiko Souma1, Gaku Kawamura2, Kanji Uchida2, Takahide Nagase1, Taisuke Jo3,4.
Abstract
INTRODUCTION: Patients with interstitial lung disease (ILD) are known to develop an acute exacerbation (AE) after surgery. Previous studies have evaluated the predictors of postoperative AE. However, it remains unclear whether the results of those studies can be generalised to patients with different types of ILD and/or extrapolated to those who undergo non-pulmonary surgery. This study aimed to elucidate the predictors of the development of AE after surgery with general anaesthesia in patients with ILD.Entities:
Keywords: clinical epidemiology; interstitial fibrosis; rare lung diseases; thoracic surgery
Year: 2020 PMID: 33115770 PMCID: PMC7594352 DOI: 10.1136/bmjresp-2020-000634
Source DB: PubMed Journal: BMJ Open Respir Res ISSN: 2052-4439
Figure 1Flow diagram of patient recruitment. AE, acute exacerbation; ILD, interstitial lung disease.
Univariate analyses before and after one-to-four matching
| Preoperative test findings | |||||||
| Factor | Total | AE | Before matching | After 1:4 matching | |||
| Non-AE | Non-AE | ||||||
| n = 700 | n = 28 | n = 672 | P value | n = 112 | P value | ||
| Preoperative SpO2 category, n (%) | |||||||
| ≥96% | 621 (89) | 18 (64) | 603 (90) | 103 (92) | |||
| 91%–95% | 47 (6.7) | 4 (14) | 43 (6.4) | 2 (1.8) | |||
| Oxygen therapy at rest | 32 (4.6) | 6 (21) | 26 (3.9) | 7 (6.2) | |||
| Honeycombing on CT, n (%) | 267 (38) | 21 (75) | 246 (37) | 42 (38) | |||
| Per cent predicted FVC category, n (%) | 0.006 | ||||||
| ≥80% | 445 (64) | 10 (36) | 435 (65) | 80 (71) | |||
| <80% | 225 (32) | 16 (57) | 209 (31) | 27 (24) | |||
| Missing | 30 (4.3) | 2 (7.1) | 28 (4.2) | 5 (4.5) | |||
| FEV1/FVC category, n (%) | 0.459 | 1 | |||||
| ≥0.70 | 509 (73) | 21 (75) | 488 (73) | 88 (82) | |||
| <0.70 | 161 (23) | 5 (18) | 156 (23) | 19 (18) | |||
| Missing | 30 (4.3) | 2 (7.1) | 28 (4.2) | 5 (4.5) | |||
| Hb category, n (%) | ≤10 g/dL | 106 (15) | 5 (18) | 101 (15) | 0.598 | 13 (12) | 0.359 |
| LD category, n (%) | >222 IU/L | 289 (41) | 12 (43) | 277 (41) | 0.848 | 44 (39) | 0.83 |
| CRP category, n (%) | >0.30 mg/dL | 297 (42) | 18 (64) | 279 (42) | 0.019 | 41 (37) | 0.01 |
| KL-6 category, n (%) | 0.007 | 0.122 | |||||
| <1000 U/mL | 444 (63) | 16 (57) | 428 (64) | 70 (63) | |||
| ≥1000 U/mL | 53 (7.6) | 7 (25) | 46 (6.8) | 12 (11) | |||
| Missing | 203 (29) | 5 (18) | 198 (30) | 30 (27) | |||
CRP, C reactive protein; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; Hb, haemoglobin; LD, lactate dehydrogenase.
Univariate analyses before and after one-to-four matching
| Characteristics of surgery | |||||||
| Factor | Total | AE | Before matching | After 1:4 matching | |||
| Non-AE | Non-AE | ||||||
| n = 700 | n = 28 | n = 672 | P value | n = 112 | P value | ||
| Year of surgery, n (%) | 0.615 | 0.961 | |||||
| 2009–2011 | 201 (29) | 7 (25) | 194 (29) | 24 (21) | |||
| 2012–2014 | 260 (37) | 13 (46) | 247 (37) | 56 (50) | |||
| 2015–2017 | 239 (34) | 8 (29) | 231 (34) | 32 (29) | |||
| Surgical site category, n (%) | |||||||
| Intrathoracic | 188 (27) | 21 (75) | 167 (25) | 40 (36) | |||
| Upper abdominal | 117 (17) | 1 (3.6) | 116 (17) | 21 (19) | |||
| Others | 395 (56) | 6 (21) | 389 (58) | 51 (46) | |||
| ASA-PS, n (%) | 0.063 | 0.29 | |||||
| 1 | 44 (6.3) | 2 (7.1) | 42 (6.2) | 11 (9.8) | |||
| 2 | 463 (66) | 17 (61) | 446 (66) | 70 (63) | |||
| 3 | 186 (27) | 7 (25) | 179 (27) | 30 (27) | |||
| 4 | 7 (1.0) | 2 (7.1) | 5 (0.7) | 1 (0.9) | |||
| Emergency surgery, n (%) | 42 (6.0) | 1 (3.6) | 41 (6.1) | 1 | 6 (5.4) | 1 | |
| Surgery duration category, n (%) | 0.374 | 0.502 | |||||
| ≤2 h | 220 (31) | 6 (21) | 214 (32) | 36 (32) | |||
| >2–3 h | 149 (21) | 5 (18) | 144 (21) | 22 (20) | |||
| >3 h | 331 (47) | 17 (61) | 314 (47) | 54 (48) | |||
| ARISCAT score category, n (%) | |||||||
| Low | 204 (29) | 1 (3.6) | 203 (30) | 27 (24) | |||
| Intermediate | 325 (46) | 7 (25) | 318 (47) | 58 (52) | |||
| High | 171 (24) | 20 (71) | 151 (23) | 27 (24) | |||
| Intraoperative blood transfusion, n (%) | 107 (15) | 7 (25) | 100 (15) | 0.175 | 19 (17) | 0.414 | |
| Multiple operations within 30 days, n (%) | 40 (5.7) | 6 (21) | 34 (5.1) | 0.004 | 24 (21) | 1 | |
ARISCAT score categories: low, <26; intermediate, 26–44; high, ≥45.
ARISCAT, Assess Respiratory Risk in Surgical Patients in Catalonia; ASA-PS, American Society of Anaesthesiologists physical status.
Figure 2Multivariable conditional logistic regression after multiple imputation. After one-to-four case–control matching for sex, year of surgery and multiple operations within 30 days, a multivariable conditional logistic regression model was performed using the following variables: honeycombing on CT, per cent predicted FVC <80%, and ARISCAT score category. The model was fitted following multiple imputation for missing values. A p value of <0.05 was considered statistically significant. ARISCAT score categories: low, <26; intermediate, 26–44; high, ≥45. ARISCAT, Assess Respiratory Risk in Surgical Patients in Catalonia; CI, confidence interval; FVC, forced vital capacity.
Univariate analyses before and after one-to-four matching
| Patient background data | |||||||
| Factor | Total | AE | Before matching | After 1:4 matching | |||
| Non-AE | Non-AE | ||||||
| n = 700 | n = 28 | n = 672 | P value | n = 112 | P value | ||
| Sex, n (%) | Male | 431 (62) | 22 (79) | 409 (61) | 0.074 | 85 (76) | 1 |
| Age category (year), n (%) | 0.145 | 0.302 | |||||
| ≤50 years | 36 (5.1) | 2 (7.1) | 34 (5.1) | 10 (8.9) | |||
| 51–80 years | 563 (80) | 19 (68) | 544 (81) | 87 (78) | |||
| >80 years | 101 (14) | 7 (25) | 94 (14) | 15 (13) | |||
| Height (cm), mean (SD) | 158.9 (9.4) | 160.0 (10.0) | 158.9 (9.3) | 0.531 | 161.9 (7.6) | 0.272 | |
| Weight (kg), mean (SD) | 57.8 (11.7) | 57.9 (11.9) | 57.8 (11.7) | 0.961 | 59.3 (11.8) | 0.597 | |
| Body mass index (kg/m2), mean (SD) | 22.8 (3.7) | 22.5 (3.3) | 22.8 (3.7) | 0.647 | 22.5 (3.5) | 0.994 | |
| Smoking status, n (%) | 0.302 | 0.214 | |||||
| Never | 285 (41) | 8 (29) | 277 (41) | 43 (38) | |||
| Former | 323 (46) | 17 (61) | 306 (46) | 47 (42) | |||
| Current | 92 (13) | 3 (11) | 89 (13) | 22 (20) | |||
| IIPs or non-IIPs, n (%) | IIPs | 416 (59) | 16 (57) | 400 (60) | 0.846 | 79 (71) | 0.183 |
| CTD-ILDs, n (%) | 237 (34) | 10 (36) | 227 (34) | 0.84 | 25 (22) | 0.151 | |
| Bronchial asthma, n (%) | 47 (6.7) | 2 (7.1) | 45 (6.7) | 0.711 | 6 (5.4) | 0.66 | |
| COPD, n (%) | 114 (16) | 8 (29) | 106 (16) | 0.11 | 18 (16.1) | 0.172 | |
| Preoperative steroid use, n (%) | 243 (35) | 7 (25) | 236 (35) | 0.316 | 19 (17) | 0.414 | |
| Respiratory infection in the last month, n (%) | 31 (4.4) | 3 (11) | 28 (4.2) | 0.122 | 7 (6.2) | 0.418 | |
The background variables, results of preoperative tests and characteristics of surgery were compared between cases and controls. Student’s t-test was used for comparisons of continuous variables. The χ2 test or Fisher’s exact test was used for comparisons of binary or categorical variables.
AE, acute exacerbation; COPD, chronic obstructive pulmonary disease; CTD-ILD, connective tissue disease-related interstitial lung disease; IIP, idiopathic interstitial pneumonia; SD, standard deviation.